Follow
Salah Khallaf
Salah Khallaf
Associated Professor of Medical Oncology, South Egypt Cancer Institute, Assiut University
Verified email at aun.edu.eg - Homepage
Title
Cited by
Cited by
Year
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado, M Sekacheva, ...
ESMO open 7 (3), 100499, 2022
182022
Interleukin-10: a potential prognostic marker in patients with newly diagnosed multiple myeloma
DA Mohammed, SM Khallaf, MGM El-Naggar, MR Abdel-Hameed, ...
Research in Oncology 17 (1), 38-41, 2021
152021
Laparoscopic versus open complete mesocolic excision for right colon cancer
A Zedan, E Elshiekh, MI Omar, M Raafat, SM Khallaf, H Atta, MT Hussien
International journal of surgical oncology 2021, 2021
132021
Is it the time to implement the routine use of distress thermometer among Egyptian patients with newly diagnosed cancer?
N Abd El-Aziz, S Khallaf, W Abozaid, G Elgohary, O Abd El-Fattah, ...
BMC cancer 20, 1-8, 2020
132020
Safety and feasibility of laparoscopic colo-rectal surgery for cancer at a tertiary center in a developing country: Egypt as an example
AT Amin, BM Ahmed, SM Khallaf
Journal of the Egyptian National Cancer Institute 27 (2), 91-95, 2015
132015
Prognostic role of monocytic myeloid-derived suppressor cells in advanced non-small-cell lung cancer: relation to different hematologic indices
AM Zahran, HF Hetta, ZAM Zahran, A Rashad, A Rayan, DO Mohamed, ...
Journal of immunology research 2021, 2021
112021
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center
SM Khallaf, J Roshdy, A Ibrahim
Journal of the Egyptian National Cancer Institute 32, 1-10, 2020
112020
Prognostic Impact of Circulating CD28 Negative Suppressor T Cells and Memory B Cells on Treatment Outcomes of Patients with Breast Cancer
AM Zahran, AS Shaltout, H Fakhry, ON Abdel Fattah, DF Temerik, ...
Iranian Journal of Immunology 17 (2), 95-110, 2020
62020
Prognostic value of CD56 expression in multiple myeloma
SM Khallaf, EA Yousof, EH Ahmed, SG Mansor, HO Mohamed, ...
Research in Oncology 16 (1), 6-10, 2020
52020
The frequency and clinical implications of lymphocyte subsets and circulating plasma cells in newly diagnosed multiple myeloma patients
AM Zahran, MM Sayed, EA Shafik, SM Khallaf, WM Mohamed, HF Hetta
Egypt J Immunol 26 (2), 117-131, 2019
42019
Bladder preservation versus radical cystectomy in transitional cell carcinoma and squamous cell carcinoma muscle invasive bladder cancer
DO Mohamed, MM Sayed, IF Abdelkawi, MH Elshoieby, SM Khallaf, ...
Current Urology 15 (1), 11-15, 2021
32021
RM-029 Outcome of continuous infusion of low dose gemcitabine in locally advanced and metastatic pancreatic carcinoma
MA Elsayed, MM Ahmed, MK Salah, MS Mohamed
Annals of Oncology 27, ii92, 2016
22016
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases
P Martin, Z Tsourti, J Ribeiro, L Castelo-Branco, E de Azambuja, ...
ESMO open 8 (3), 101566, 2023
12023
1567MO COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE)
E Romano, S Gennatas, J Rogado, M Sekacheva, D Viñal, R Lee, ...
Annals of Oncology 32, S1133, 2021
12021
Is Survival with Conservative Breast Therapy Becoming Superior to That with Modified Radical Mastectomy Alone for the Treatment of Early Breast Cancer in This Era?
MM Sayed, DO Mohamed, MSF Hassan, MH Elshoieby, MS Elnaggar, ...
Indian Journal of Surgical Oncology, 1-6, 2020
12020
Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study
E Shafik, DA Mohareb, H Hetta, A el-Rady, Z Gaber, MZ Abu Rahma, ...
International Journal of Cancer and Biomedical Research 4 (2), 121-131, 2020
12020
Prolonged Infusion of Low Dose Gemcitabine in Advanced Pancreatic Carcinoma
E Ali, A Maklad, S Khallaf
Journal of Cancer Therapy 11 (7), 401-409, 2020
12020
Cardiac Safety with High Cumulative Dose of Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer Previously Treated with Conventional Anthracyclines
Salah Mabrouk Khallaf, Ahmed Refaat, Dalia O. Mohamed, Elsayed Mostafa Ali
Advances in Breast Cancer Research 9 (3), 55-65, 2020
12020
Predictive and prognostic factors for the outcome of the patients receiving pegylated liposomal doxorubicin for advanced breast cancer
SM Khallaf, J Roshdy, A Ibrahim
Advances in Breast Cancer Research 9 (02), 21-33, 2020
12020
Primary Debulking Surgery for Stage III Epithelial Ovarian Cancer Has a Better Outcome Than Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery
AT Amin, BM Ahmed, A Refaat, SA Sileem, SM Khallaf
Journal of Cancer Therapy 11 (3), 142-153, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20